Authors: Ferrero, D Foli, C Giaretta, F Argentino, C Rus, C Pileri, A

Citation: D. Ferrero et al., Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +/- alpha-interferon, LEUKEMIA, 15(3), 2001, pp. 422-429

Authors: Palumbo, A Giaccone, L Bertola, A Pregno, P Bringhen, S Rus, C Triolo, S Gallo, E Pileri, A Boccadoro, M

Citation: A. Palumbo et al., Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma, HAEMATOLOG, 86(4), 2001, pp. 399-403

Authors: Palumbo, A Triolo, S Argentino, C Bringhen, S Dominietto, A Rus, C Omede, P Tarella, C Pileri, A Boccadoro, M

Citation: A. Palumbo et al., Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients, BLOOD, 94(4), 1999, pp. 1248-1253